BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15702733)

  • 1. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study.
    Gill SS; Rochon PA; Herrmann N; Lee PE; Sykora K; Gunraj N; Normand SL; Gurwitz JH; Marras C; Wodchis WP; Mamdani M
    BMJ; 2005 Feb; 330(7489):445. PubMed ID: 15668211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia.
    Lee PE; Gill SS; Rochon P
    Neuropsychiatr Dis Treat; 2006 Dec; 2(4):521-9. PubMed ID: 19412500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence.
    Mittal V; Kurup L; Williamson D; Muralee S; Tampi RR
    Am J Alzheimers Dis Other Demen; 2011 Feb; 26(1):10-28. PubMed ID: 21282274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The harms of benzodiazepines for patients with dementia.
    Rochon PA; Vozoris N; Gill SS
    CMAJ; 2017 Apr; 189(14):E517-E518. PubMed ID: 28396327
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study.
    Shin JY; Choi NK; Jung SY; Lee J; Kwon JS; Park BJ
    J Psychopharmacol; 2013 Jul; 27(7):638-44. PubMed ID: 23535349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A schizophrenic patient with cerebral infarctions after hemorrhagic shock.
    Yanagawa Y; Ohara K; Tanaka Y; Tanaka R
    J Emerg Trauma Shock; 2013 Jan; 6(1):53-5. PubMed ID: 23493336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial).
    Litvinenko IV; Odinak MM; Mogil'naya VI; Emelin AY
    Neurosci Behav Physiol; 2008 Nov; 38(9):937-45. PubMed ID: 18975103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to atypical antipsychotics for the management of dementia-related agitation.
    Passmore MJ; Gardner DM; Polak Y; Rabheru K
    Drugs Aging; 2008; 25(5):381-98. PubMed ID: 18447403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A composite screening tool for medication reviews of outpatients: general issues with specific examples.
    De Smet PA; Denneboom W; Kramers C; Grol R
    Drugs Aging; 2007; 24(9):733-60. PubMed ID: 17727304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do atypical antipsychotics cause stroke?
    Herrmann N; Lanctôt KL
    CNS Drugs; 2005; 19(2):91-103. PubMed ID: 15697324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van der Mast RC
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):726-7; author reply 727. PubMed ID: 15819141
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
    Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van Marum RJ; Jansen PA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics and risk of cerebrovascular accidents.
    Herrmann N; Mamdani M; Lanctôt KL
    Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
    Layton D; Harris S; Wilton LV; Shakir SA
    J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.